NASDAQ · Analyst Forecast

Avita Medical, Inc. (RCEL) Stock Forecast & Price Target

$15.77 NASDAQ: RCEL Market Cap $391.77M

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 18, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Avita Medical, Inc. (RCEL), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Avita Medical, Inc., analysts forecast revenue rising from $71.49M in 2025 to $497.55M in 2030; the average estimate for 2030 earnings per share is $3.62; with published estimates ranging from $3.42 to $3.82; 6 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$15.77
Consensus targetThe average of the price targets analysts have published.$14.33
Median targetThe middle target, less affected by a single outlier.$12.00
Highest targetThe most optimistic published target.$20.00
Lowest targetThe most pessimistic published target.$11.00
Difference from priceHow far the consensus target sits from today’s price.-9.1%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$68.45M$71.49M$74.58M3
2026$89.27M$93.24M$97.27M5
2027$110.22M$115.11M$120.08M5
2028$127.75M$136.85M$145.78M6
2029$393.86M$411.37M$429.13M4
2030$476.37M$497.55M$519.02M3

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$1.82−$1.80−$1.773
2026−$0.96−$0.91−$0.865
2027−$0.39−$0.37−$0.355
2028−$0.01$0.01$0.026
2029$2.61$2.76$2.914
2030$3.42$3.62$3.823

Avita Medical, Inc. (RCEL) forecast — frequently asked questions

What is the analyst price target for Avita Medical, Inc.?

Analysts covering Avita Medical, Inc. (RCEL) have a consensus price target of $14.33, 9.1% below the current price of $15.77. Published targets range from $11.00 to $20.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Avita Medical, Inc.'s earnings?

The average analyst estimate for Avita Medical, Inc. (RCEL) earnings per share in 2030 is 3.62, with individual estimates between 3.42 and 3.82.

How much revenue is Avita Medical, Inc. expected to make?

Analysts forecast Avita Medical, Inc. (RCEL) revenue of $497.55M in 2030, based on 3 published estimates.

How many analysts cover RCEL?

6 analysts contribute estimates for Avita Medical, Inc. (RCEL). Thin coverage makes an average less reliable.

Analyst forecasts for other Medical - Devices stocks

ABT forecastISRG forecastMDT forecastSYK forecastBSX forecastEW forecastRMD forecastDXCM forecastPHG forecastZBH forecastAll Medical - Devices stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.